Skip to main content

Table 4 Multivariable overall survival analysis for 127 patients with CMML

From: Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia

Parameters HR 95%CI P value
Hb < 100 g/L vs ≥100 g/L 2.42 1.40–4.19 0.002
IMCs presence vs absence 2.08 1.25–3.46 0.005
ASXL1 mut vs wt 1.99 1.20–3.28 0.007